The landscape of dementia prognosis has progressed considerably with the appearance of advanced biomarkers, like amyloid PET scans, tau imaging, and blood-centered tests that may detect Alzheimer's pathology several years in advance of symptoms emerge. Whilst these technological developments symbolize amazing development in knowledge neurodegenerat